Published in Ann Rheum Dis on October 24, 2008
2,3,7,8-tetrachlorodibenzo-p-dioxin induces transcriptional activity of the human polymorphic hs1,2 enhancer of the 3'Igh regulatory region. J Immunol (2012) 0.86
Position and sequence conservation in Amniota of polymorphic enhancer HS1.2 within the palindrome of IgH 3'Regulatory Region. BMC Evol Biol (2011) 0.85
Toward understanding the role of aryl hydrocarbon receptor in the immune system: current progress and future trends. Biomed Res Int (2014) 0.84
The aryl hydrocarbon receptor regulates an essential transcriptional element in the immunoglobulin heavy chain gene. Cell Immunol (2015) 0.76
The change in Ig regulation from children to adults disconnects the correlation with the 3'RR hs1.2 polymorphism. BMC Immunol (2014) 0.75
The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region. Toxicol Sci (2015) 0.75
Evidence for a quadruplex structure in the polymorphic hs1.2 enhancer of the immunoglobulin heavy chain 3' regulatory regions and its conservation in mammals. Biopolymers (2016) 0.75
Allelic frequencies of the hs1.2 enhancer within the immunoglobulin heavy chain region in Dayton, Ohio patients screened for celiac disease with duodenal biopsy. Dig Liver Dis (2017) 0.75
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet (2004) 13.71
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. N Engl J Med (2007) 12.24
Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med (2001) 7.41
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum (2000) 6.88
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum (2005) 5.18
Localization of the 3' IgH locus elements that effect long-distance regulation of class switch recombination. Immunity (2001) 1.95
HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol (1995) 1.58
Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev (2006) 1.16
Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease. Scand J Gastroenterol (2004) 1.03
Evolution of human IgH3'EC duplicated structures: both enhancers HS1,2 are polymorphic with variation of transcription factor's consensus sites. Gene (2004) 1.02
Alleles of the alpha1 immunoglobulin gene 3' enhancer control evolution of IgA nephropathy toward renal failure. Kidney Int (2000) 1.01
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J Invest Dermatol (2008) 0.99
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann Rheum Dis (2007) 0.95
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75
Intracranial hypertension in head injury: management and results. Intensive Care Med (1999) 2.21
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. BJOG (2012) 2.14
A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen. Br J Cancer (2006) 1.85
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A (2001) 1.84
Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs (2008) 1.69
Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A (2010) 1.67
Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology (2000) 1.64
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth (2006) 1.64
An mRNA maturase is encoded by the first intron of the mitochondrial gene for the subunit I of cytochrome oxidase in S. cerevisiae. Cell (1983) 1.64
Hypokalaemic alkalosis, acquired Gitelman's and Bartter's syndrome in chronic sialoadenitis. Br J Rheumatol (1997) 1.63
Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis. Gastroenterology (1992) 1.58
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Ann Oncol (2007) 1.52
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein. Clin Rheumatol (2012) 1.52
Giardia lamblia infestation reveals underlying Whipple's disease in a patient with longstanding constipation. Am J Gastroenterol (1991) 1.48
HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum (1988) 1.48
Hepatitis B virus antigens in peripheral blood mononuclear cells during the course of viral infection. Clin Immunol Immunopathol (1994) 1.46
Selective endoscopic retrograde cholangiography and preoperative bile duct stone removal in patients scheduled for laparoscopic cholecystectomy: a prospective study. Am J Gastroenterol (1996) 1.45
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl (2009) 1.43
Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis. Am J Gastroenterol (1990) 1.41
Esophageal motor disorders in patients evaluated for dysphagia and/or noncardiac chest pain. Dysphagia (1992) 1.39
Intragastric pH monitoring during antisecretory therapy in patient with gastrointestinal bleeding. Am J Gastroenterol (1989) 1.38
Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci (1986) 1.37
Colonic mass movements in idiopathic chronic constipation. Gut (1988) 1.36
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A (2001) 1.31
The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut (2005) 1.29
Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci (1999) 1.29
Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut (1994) 1.27
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 1.24
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology (1999) 1.22
The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr Relat Cancer (2000) 1.22
Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology (1997) 1.22
Discriminating ability of composite indices for measuring disease activity in rheumatoid arthritis: a comparison of the Chronic Arthritis Systemic Index, Disease Activity Score and Thompson's articular index. Rheumatology (Oxford) (2000) 1.18
Spectrum of clinical variability in familial deletion 22q11.2: from full manifestation to extremely mild clinical anomalies. Clin Genet (2003) 1.18
Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domain. J Biol Chem (1989) 1.18
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci U S A (2001) 1.14
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum (2007) 1.14
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement. Med Oncol (2011) 1.14
IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. J Immunol (2000) 1.14
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol (1999) 1.13
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 1.13
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13
Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology (1995) 1.10
Clinical trials in rheumatoid arthritis: methodological suggestions for assessing radiographs arising from the GRISAR Study. Gruppo Reumatologi Italiani Studio Artrite Reumatoide. Ann Rheum Dis (1997) 1.10
Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum (1997) 1.09
Biofeedback for pelvic floor dysfunction in constipation. BMJ (2004) 1.09
Preoperative embolization in surgical treatment of mediastinal hemangiopericytoma. Ann Thorac Surg (2000) 1.08
Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J Biol Chem (1997) 1.08
Hypogonadism and metabolic syndrome. J Endocrinol Invest (2011) 1.07
Gynecomastia during omeprazole therapy. N Engl J Med (1991) 1.07
The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J (2000) 1.06
tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1. Cell Death Differ (2005) 1.06
Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity. Cancer Res (1985) 1.05
Insulin-like growth factor binding proteins 4 and 7 released by senescent cells promote premature senescence in mesenchymal stem cells. Cell Death Dis (2013) 1.04
Mortality of plastic-ware workers exposed to radiofrequencies. Bioelectromagnetics (1997) 1.04
Update of the follow-up of mortality and cancer incidence among European workers employed in the vinyl chloride industry. Epidemiology (2001) 1.03
Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth (2009) 1.03
Identification of muscarinic receptor subtype mediating colonic response to eating. Dig Dis Sci (1985) 1.03
17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway. J Cell Physiol (2001) 1.03
Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology (1996) 1.03
Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease. Scand J Gastroenterol (2004) 1.03
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res (2002) 1.02
[Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines]. Actas Urol Esp (2012) 1.02
The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther (2005) 1.02
In vivo induction of macrophage Ia antigen (MHC class II) expression by biomedical polymers in the cage implant system. J Biomed Mater Res (1994) 1.00
Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest (1997) 1.00
Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells. Cancer Res (1999) 1.00
Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology (2000) 1.00
False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children. Pediatrics (1994) 1.00
Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol (1981) 1.00
Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci (1996) 0.99
Mortality study of workers employed by the Italian National Institute of Health, 1960-1989. Scand J Work Environ Health (1992) 0.99
Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome. Histopathology (1997) 0.99
GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut (2006) 0.99
Metabolic profiling by 13C-NMR spectroscopy: [1,2-13C2]glucose reveals a heterogeneous metabolism in human leukemia T cells. Biochimie (2005) 0.99
Genetic effects of PR toxin in eukaryotic microorganisms. Environ Mutagen (1979) 0.98
Differentiation and apoptosis of neuroblastoma cells: role of N-myc gene product. J Cell Biochem (1999) 0.98
Mechanism of non-steroidal anti-inflammatory drug-gastropathy. Dig Liver Dis (2001) 0.98
Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. Am J Gastroenterol (1989) 0.98
Upper gastrointestinal motor abnormalities in children with active celiac disease. J Pediatr Gastroenterol Nutr (1995) 0.97
Cancer risk among female agricultural workers: a multi-center case-control study. Am J Ind Med (1999) 0.97
RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells. Int J Cancer (2000) 0.97
Endodermal sinus tumor of the mediastinum. A report of seven cases and review of the literature. Cancer (1986) 0.97
Type of estrogen receptor determines response to antiestrogen therapy. Cancer Res (1996) 0.97
Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor. J Biol Chem (1999) 0.97
Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation. Dig Dis Sci (1993) 0.97
Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2011) 0.97
Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency. Proc Natl Acad Sci U S A (1978) 0.96
Evaluation of the activity of anti-inflammatory agents by means of skin tests (M.S.U., SK-SD): comparison with clinical results. Eur J Rheumatol Inflamm (1981) 0.96
Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus. Lancet (1979) 0.96
EUROPLAN: a project to support the development of national plans on rare diseases in Europe. Public Health Genomics (2014) 0.96
The effects of NSAID on monosodium-urate (MSU) skin test and on other in vivo skin tests (SK/SD; PHA). Agents Actions Suppl (1980) 0.96
Septic sacroiliitis: an uncommon septic arthritis. Clin Exp Rheumatol (2010) 0.96
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. Ann Oncol (2011) 0.95
Human colonic motility: physiological aspects. Int J Colorectal Dis (1995) 0.95